<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://www.fda.gov/oc/datacouncil/stylesheets/spl/spl.xsl" type="text/xsl"?><document xmlns="urn:hl7-org:v3" xmlns:voc="http://www.hl7.org/v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 http://www.fda.gov/oc/datacouncil/schemas/spl/spl.xsd">
<id root="dad7735c-709b-40ea-ab7a-15577e24a966" />
<code code="34391-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="HUMAN PRESCRIPTION DRUG LABELING" />
<title ID="INV-fdfda890-b3c2-4728-8f68-24b2af219d23" mediaType="text/x-hl7-title+xml">Lactated Ringer&#8217;s Injection, USP<br />in
        VIAFLEX Plastic Container</title>
<effectiveTime value="20060608" />
<setId root="dad7735c-709b-40ea-ab7a-15577e24a966" />
<versionNumber value="1" />
<author>
<time />
<assignedEntity>
<representedOrganization>
<name>Baxter Healthcare Corporation</name>
</representedOrganization>
</assignedEntity>
</author>
<component>
<structuredBody>
<component>
<section>
<id root="53B71D92-7502-1AB3-5819-BDB61C88A9D7" />
<effectiveTime value="20060608" />
<subject>
<manufacturedProduct>
<manufacturedMedicine>
<code code="0338-0117" codeSystem="2.16.840.1.113883.6.69" />
<name>Lactated Ringers</name>
<formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION" />
<activeIngredient>
<quantity>
<numerator unit="mg" value="600">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="600" />
</numerator>
<denominator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Sodium Chloride</name>
<activeMoiety>
<activeMoiety>
<code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>sodium chloride</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<activeIngredient>
<quantity>
<numerator unit="mg" value="310">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="310" />
</numerator>
<denominator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="TU7HW0W0QT" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Sodium Lactate</name>
<activeMoiety>
<activeMoiety>
<code code="TU7HW0W0QT" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>sodium lactate</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<activeIngredient>
<quantity>
<numerator unit="mg" value="30">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="30" />
</numerator>
<denominator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Potassium Chloride</name>
<activeMoiety>
<activeMoiety>
<code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>potassium chloride</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<activeIngredient>
<quantity>
<numerator unit="mg" value="20">
<translation code="C28253" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLIGRAM" value="20" />
</numerator>
<denominator unit="mL" value="100">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="100" />
</denominator>
</quantity>
<activeIngredientSubstance>
<code code="M4I0D6VV5M" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>Calcium Chloride</name>
<activeMoiety>
<activeMoiety>
<code code="M4I0D6VV5M" codeSystem="2.16.840.1.113883.4.9" codeSystemName="FDA SRS" />
<name>calcium chloride</name>
</activeMoiety>
</activeMoiety>
</activeIngredientSubstance>
</activeIngredient>
<asEntityWithGeneric>
<genericMedicine>
<name>Sodium chloride, potassium chloride, sodium lactate and calcium chloride</name>
</genericMedicine>
</asEntityWithGeneric>
<inactiveIngredient>
<inactiveIngredientSubstance>
<name>Water</name>
</inactiveIngredientSubstance>
</inactiveIngredient>
<asContent>
<quantity>
<numerator unit="mL" value="250">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="250" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0338-0117-02" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="mL" value="500">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="500" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0338-0117-03" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
</containerPackagedMedicine>
</asContent>
<asContent>
<quantity>
<numerator unit="mL" value="1000">
<translation code="C28254" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MILLILITER" value="1000" />
</numerator>
<denominator value="1">
<translation codeSystem="2.16.840.1.113883.3.26.1.1" value="1" />
</denominator>
</quantity>
<containerPackagedMedicine>
<code code="0338-0117-04" codeSystem="2.16.840.1.113883.6.69" />
<formCode code="C43167" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BAG" />
</containerPackagedMedicine>
</asContent>
</manufacturedMedicine>
<consumedIn>
<substanceAdministration>
<routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS" />
</substanceAdministration>
</consumedIn>
</manufacturedProduct>
</subject>
</section>
</component>
<component>
<section ID="INV-64601724-ad92-4ff0-8bfb-6da906dc23d3">
<id root="8771D7C6-D586-BBB1-3905-9534B90BB749" />
<code code="34089-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="DESCRIPTION SECTION" />
<title ID="INV-ffa4c872-ffcc-4219-9a69-91195ba78c1b" mediaType="text/x-hl7-title+xml">DESCRIPTION</title>
<text ID="INV-e18151e4-b141-464f-bec8-689cf2a6cce4"><paragraph ID="INV-2a3923e5-1400-44b3-b81b-3b9b0d0238a7">Lactated Ringer&#8217;s
                            Injection, USP is a sterile, nonpyrogenic solution for fluid and
                            electrolyte replenishment in single dose containers for intravenous
                            administration. It contains no antimicrobial agents. Composition,
                            osmolarity, pH, ionic concentration and caloric content are shown in
                            Table 1.</paragraph><table border="1" frame="border"><col align="left" width="60pt" />
<col align="left" width="40pt" />
<col align="left" width="60pt" />
<col align="left" width="67pt" />
<col align="left" width="62pt" />
<col align="left" width="67pt" />
<col align="left" width="71pt" />
<col align="left" width="75pt" />
<col align="left" width="49pt" />
<col align="left" width="53pt" />
<col align="left" width="52pt" />
<col align="left" width="53pt" />
<col align="left" width="47pt" />
<col align="left" width="59pt" />
<tbody valign="top">
<tr valign="top"><td align="center" rowspan="2" styleCode="Botrule Lrule Rrule" valign="middle"><content styleCode="bold">Table 1</content></td><td align="center" rowspan="2" styleCode="Botrule                                         Rrule" valign="middle"> Size (mL) </td><td align="center" colspan="4" styleCode="Botrule Rrule" valign="middle"> Composition (g/L) </td><td align="center" rowspan="2" styleCode="Botrule                                         Rrule" valign="middle"> Osmolarity (mOsmol/L) (calc) </td><td align="center" rowspan="2" styleCode="Botrule                                         Rrule" valign="middle"> pH </td><td align="center" colspan="5" styleCode="Botrule                                         Rrule" valign="middle"> Ionic Composition (mEq/L) </td><td align="center" rowspan="2" styleCode="Botrule                                         Rrule" valign="middle"> Caloric Content (kcal/L) </td></tr>
<tr valign="top"><td align="center" styleCode="Botrule Lrule Rrule" valign="middle">Sodium Chloride, USP, (NaCl)</td><td align="center" styleCode="Botrule Rrule" valign="middle">Sodium Lactate, (C<sub>3</sub>H<sub>5</sub>NaO<sub>3</sub>)</td><td align="center" styleCode="Botrule Rrule" valign="middle">Potassium Chloride, USP, (KCl)</td><td align="center" styleCode="Botrule Rrule" valign="middle">Calcium Chloride, USP (CaCl<sub>2</sub>&#183;2H<sub>2</sub>O)</td><td align="center" styleCode="Botrule Rrule" valign="middle">Sodium</td><td align="center" styleCode="Botrule Rrule" valign="middle"><content styleCode="bold">Potassium</content></td><td align="center" styleCode="Botrule Rrule" valign="middle">Calcium</td><td align="center" styleCode="Botrule Rrule" valign="middle">Chloride</td><td align="center" styleCode="Botrule Rrule" valign="middle">Lactate</td></tr>
<tr valign="top"><td align="left" rowspan="3" styleCode="Botrule                                         Lrule Rrule" valign="middle"> Lactated Ringer&#8217;s Injection, USP </td><td align="center" styleCode="Botrule Rrule" valign="middle"> 250 </td><td align="center" rowspan="3" styleCode="Botrule                                         Rrule" valign="middle"> 6 </td><td align="center" rowspan="3" styleCode="Botrule                                         Rrule" valign="middle"> 3.1 </td><td align="center" rowspan="3" styleCode="Botrule                                         Rrule" valign="middle"> 0.3 </td><td align="center" rowspan="3" styleCode="Botrule                                         Rrule" valign="middle"> 0.2 </td><td align="center" rowspan="3" styleCode="Botrule                                         Rrule" valign="middle"> 273 </td><td align="center" rowspan="3" styleCode="Botrule Rrule" valign="middle"> 6.5 <br />(6.0 to 7.5) </td><td align="center" rowspan="3" styleCode="Botrule Rrule" valign="middle"> 130 </td><td align="center" rowspan="3" styleCode="Botrule Rrule" valign="middle"><content styleCode="bold">4</content></td><td align="center" rowspan="3" styleCode="Botrule Rrule" valign="middle"> 2.7 </td><td align="center" rowspan="3" styleCode="Botrule Rrule" valign="middle"> 109 </td><td align="center" rowspan="3" styleCode="Botrule Rrule" valign="middle"> 28 </td><td align="center" rowspan="3" styleCode="Botrule Rrule" valign="middle"> 9 </td></tr>
<tr valign="top"><td align="center" styleCode="Botrule Lrule Rrule" valign="middle">500</td></tr>
<tr valign="top"><td align="center" styleCode="Botrule Lrule Rrule" valign="middle">1000</td></tr>
</tbody>
</table><paragraph ID="INV-e5ef41ff-91ee-438c-afa5-562e43188e48">The VIAFLEX plastic
                            container is fabricated from a specially formulated polyvinyl chloride
                            (PL 146 Plastic). The amount of water that can permeate from inside the     container into the overwrap is insufficient to affect the solution
                            significantly. Solutions in contact with the plastic container can leach
                            out certain of its chemical components in very small amounts within the
                            expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts
                            per million. However, the safety of the plastic has been confirmed in
                            tests in animals according to USP biological tests for plastic
                            containers as well as by tissue culture toxicity studies.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-bf9470bc-ddfe-4d62-bcd4-32c414bfe94c">
<id root="EDE07D2B-DED1-3CE1-54FD-BA74540137D3" />
<code code="34090-1" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="CLINICAL PHARMACOLOGY SECTION" />
<title ID="INV-34d80d54-3446-435f-913e-880a87307eb3" mediaType="text/x-hl7-title+xml">CLINICAL PHARMACOLOGY</title>
<text ID="INV-2e85707b-072c-4113-b225-060c4cd67de0"><paragraph ID="INV-88407cef-894d-4e99-9058-e155d19240a8">Lactated Ringer&#8217;s
                            Injection, USP has value as a source of water and electrolytes. It is
                            capable of inducing diuresis depending on the clinical condition of the
                            patient.</paragraph><paragraph ID="INV-0c96bff2-b9fa-4fa4-9525-447ec00ea981">Lactated Ringer&#8217;s
                            Injection, USP produces a metabolic alkalinizing effect. Lactate ions
                            are metabolized ultimately to carbon dioxide and water, which requires
                            the consumption of hydrogen cations.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-95686bda-6a10-4b07-be20-56b1a18e594c">
<id root="04D09E9B-D613-79F7-B8AC-31C115E1BD43" />
<code code="34067-9" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="INDICATIONS AND USAGE SECTION" />
<title ID="INV-f7a108d9-1b55-4e11-9006-9cdfccf4a54f" mediaType="text/x-hl7-title+xml">INDICATIONS AND USAGE</title>
<text ID="INV-03a5968d-09ac-497d-9c66-2bd3bbf7a125"><paragraph ID="INV-d3a8a618-61a9-497b-9cae-a28d4a62003f">Lactated Ringer&#8217;s
                            Injection, USP is indicated as a source of water and electrolytes or as
                            an alkalinizing agent.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-13ff7959-b07d-421d-b49e-a8c733db6f08">
<id root="FFB9B512-B733-69D8-AB86-C0FFDCEF5318" />
<code code="34070-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="CONTRAINDICATIONS SECTION" />
<title ID="INV-03565abd-603e-4e20-accc-0caee0dc6df6" mediaType="text/x-hl7-title+xml">CONTRAINDICATIONS</title>
<text ID="INV-ca3be693-8421-40b9-ac20-95286ad033ce"><paragraph ID="INV-72114844-ad7b-4b0f-92bb-965359d56836">None
                        known</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-3702da0b-318a-4a06-a170-8fd1379df18c">
<id root="177CF354-B27D-2074-0543-BB2D1002FD90" />
<code code="34071-1" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="WARNINGS SECTION" />
<title ID="INV-0c0d162e-c232-44a1-bda3-2c579bf1af3c" mediaType="text/x-hl7-title+xml">WARNINGS</title>
<text ID="INV-b96bb9f5-f1cc-4338-8dfd-74b04bc6bcf4"><paragraph ID="INV-92801183-39e7-4802-8bad-e459db8b23a0">Lactated Ringer&#8217;s
                            Injection, USP should be used with great care, if at all, in patients
                            with congestive heart failure, severe renal insufficiency, and in
                            clinical states in which there exists edema with sodium retention.</paragraph><paragraph ID="INV-705070bb-e648-457d-ba85-3abe94dc382e">Lactated Ringer&#8217;s
                            Injection, USP should be used with great care, if at all, in patients
                            with hyperkalemia, severe renal failure, and in conditions in which
                            potassium retention is present.</paragraph><paragraph ID="INV-35a3fb93-bdd7-4804-9758-c8419e77de8e">Lactated Ringer&#8217;s
                            Injection, USP should be used with great care in patients with metabolic
                            or respiratory alkalosis. The administration of lactate ions should be
                            done with great care in those conditions in which there is an increased
                            level or an impaired utilization of these ions, such as severe hepatic
                            insufficiency.</paragraph><paragraph ID="INV-405b696c-f421-45c4-a188-6f7a71534c9b">Lactated Ringer&#8217;s
                            Injection, USP should not be administered simultaneously with blood
                            through the same administration set because of the likelihood of
                            coagulation.</paragraph><paragraph ID="INV-7478efac-a641-4f12-9f05-23cf54d258b5">The intravenous
                            administration of Lactated Ringer&#8217;s Injection, USP can cause fluid
                            and/or solute overloading resulting in dilution of serum electrolyte                            concentrations, overhydration, congested states, or pulmonary edema. The
                            risk of dilutional states is inversely proportional to the electrolyte
                            concentrations of the injections. The risk of solute overload causing
                            congested states with peripheral and pulmonary edema is directly
                            proportional to the electrolyte concentrations of the injections.</paragraph><paragraph ID="INV-dee2c8c3-13b4-48fd-91c0-83854e67524b">In patients with
                            diminished renal function, administration of Lactated Ringer&#8217;s
                            Injection, USP may result in sodium or potassium retention.</paragraph><paragraph ID="INV-d9e28820-0914-456d-827b-fe81518be821">Lactated Ringer&#8217;s
                            Injection, USP is not for use in the treatment of lactic
                        acidosis.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-00993beb-0ad0-4d27-bc6b-1e2e1ef9177b">
<id root="50C591E9-D218-7956-313C-A43E6FFDE460" />
<code code="42232-9" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="PRECAUTIONS SECTION" />
<title ID="INV-a913cb95-d655-42d4-9eaa-70d301d16c3e" mediaType="text/x-hl7-title+xml">PRECAUTIONS</title>
<text ID="INV-a13fc3ac-a287-443a-812a-d1a547bcf82c"><paragraph ID="INV-aba5c72d-8c25-4c00-afda-0b4f49bb3b44">Clinical evaluation
                            and periodic laboratory determinations are necessary to monitor changes
                            in fluid balance, electrolyte concentrations, and acid base balance
                            during prolonged parenteral therapy or whenever the condition of the
                            patient warrants such evaluation.</paragraph><paragraph ID="INV-5a4366b2-ce23-47bc-8065-517103a708c2">Lactated Ringer&#8217;s
                            Injection, USP must be used with caution. Excess administration may
                            result in metabolic alkalosis.</paragraph><paragraph ID="INV-70c93607-984a-4f76-81ed-c891895cdb20">Caution must be
                            exercised in the administration of Lactated Ringer&#8217;s Injection, USP to
                            patients receiving corticosteroids or corticotropin.</paragraph></text>
<effectiveTime value="20060608" />
<component>
<section ID="INV-5c253037-3169-4f57-854f-86bf27211875">
<id root="63931FDD-0CDC-1181-75CF-03B6514420A9" />
<code code="42228-7" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="PREGNANCY" />
<title ID="INV-2676264e-2622-4aed-8b49-d8777c88d7dc" mediaType="text/x-hl7-title+xml">Pregnancy</title>
<effectiveTime value="20060608" />
<component>
<section ID="INV-65aeaa78-4b40-4c0f-8984-532885fc29db">
<id root="721E9426-F0D9-65BD-84B1-6DEA0EA537B5" />
<code code="34077-8" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="TERATOGENIC EFFECTS SECTION" />
<title ID="INV-2d56912d-874c-4451-8329-f0418b427a4d" mediaType="text/x-hl7-title+xml">Teratogenic
                                        Effects</title>
<effectiveTime value="20060608" />
<component>
<section>
<id root="9408DEAC-1C57-D7CB-BAD6-ACF6E4624CC2" />
<title ID="INV-1add8f04-f39a-44ff-aa62-0d29c4d4cdae" mediaType="text/x-hl7-title+xml">Pregnancy Category C</title>
<text ID="INV-35b09680-fc47-4666-ac67-14cb113b405e"><paragraph ID="INV-913b7291-9343-4609-a94c-7d7cf1fb324b">Animal reproduction studies have not been
                                                  conducted with Lactated Ringer&#8217;s Injection, USP.
                                                  It is also not known whether Lactated Ringer&#8217;s
                                                  Injection, USP can cause fetal harm when
                                                  administered to a pregnant woman or can affect
                                                  reproduction capacity. Lactated Ringer&#8217;s   Injection, USP should be given to a pregnant
                                                  woman only if clearly needed.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
</section>
</component>
</section>
</component>
<component>
<section ID="INV-95f79c5c-2778-4c0e-8063-78243b2e0f10">
<id root="F2C6200D-544C-9766-2858-42EEC9F0727F" />
<code code="34081-0" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="PEDIATRIC USE SECTION" />
<title ID="INV-92d81018-5fa2-462d-9a9c-6c49dab52860" mediaType="text/x-hl7-title+xml">Pediatric Use</title>
<text ID="INV-d193aeb3-d94d-42a9-9af3-02abb77077aa"><paragraph ID="INV-7a58bf7f-d897-4aec-9040-6d4d13486bad">Safety and
                                    effectiveness of Lactated Ringer&#8217;s Injection, USP in pediatric
                                    patients have not been established by adequate and well
                                    controlled trials, however, the use of electrolyte solutions in
                                    the pediatric population is referenced in the medical
                                    literature. The warnings, precautions and adverse reactions
                                    identified in the label copy should be observed in the pediatric
                                    population.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-2fc20330-7a7e-41c7-9942-b4bfb2637693">
<id root="70684688-DBEC-6EF2-C252-352C84AEFECB" />
<code code="34082-8" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="GERIATRIC USE SECTION" />
<title ID="INV-dbf753ff-5d13-4c9f-8eb6-b0790e0c0a3e" mediaType="text/x-hl7-title+xml">Geriatric Use</title>
<text ID="INV-5e32f3e4-e27b-47f5-b3f5-8e656d85da33"><paragraph ID="INV-25aa7cd5-9272-47e5-8d59-b747eb8025e4">Clinical           studies of Lactated Ringer&#8217;s Injection, USP did not include
                                    sufficient numbers of subjects aged 65 and over to determine
                                    whether they respond differently from younger subjects. Other
                                    reported clinical experience has not identified differences in
                                    responses between the elderly and younger patients. In general,
                                    dose selection for an elderly patient should be cautious,
                                    usually starting at the low end of the dosing range, reflecting                              the greater frequency of decreased hepatic, renal, or cardiac
                                    function, and of concomitant disease or drug therapy.</paragraph><paragraph ID="INV-d54090dc-403a-4743-ab4f-615de3e606d8">Do not
                                    administer unless solution is clear and seal is
                                intact.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
</section>
</component>
<component>
<section ID="INV-0938fd63-b672-4596-8cb9-abcbef8b4aae">
<id root="EE63EB10-695A-8988-6F74-6DD19612CFC4" />
<code code="34084-4" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="ADVERSE REACTIONS SECTION" />
<title ID="INV-dc12e031-bc8c-4184-a570-d26f1e511f9b" mediaType="text/x-hl7-title+xml">ADVERSE REACTIONS</title>
<text ID="INV-082627f3-d883-4d50-a649-323a1c53c3cf"><paragraph ID="INV-d102874c-5e09-459a-be53-4680e3a48b91">Allergic reactions
                            or anaphylactoid symptoms such as localized or generalized urticaria and
                            pruritis; periorbital, facial, and/or laryngeal edema; coughing,
                            sneezing, and/or difficulty with breathing have been reported during
                            administration of Lactated Ringer&#8217;s Injection, USP. The reporting
                            frequency of these signs and symptoms is higher in women during
                            pregnancy.</paragraph><paragraph ID="INV-0a8698a9-0aca-4dd6-98a3-5a6fc5d648d5">Reactions which may
                            occur because of the solution or the technique of administration include
                            febrile response, infection at the site of injection, venous thrombosis                        or phlebitis extending from the site of injection, extravasation, and
                            hypervolemia.</paragraph><paragraph ID="INV-5f64e1f1-b7bb-46d2-87dd-3106171488b0">If an adverse
                            reaction does occur, discontinue the infusion, evaluate the patient,
                            institute appropriate therapeutic countermeasures, and save the
                            remainder of the fluid for examination if deemed necessary.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-ac2c45fe-f973-402a-8bad-3fd52b802b62">
<id root="9C205E9C-588A-CB8D-9A97-95F7914B33CD" />
<code code="34068-7" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="DOSAGE AND ADMINISTRATION SECTION" />
<title ID="INV-4677976a-a194-41ab-a39d-c80a8534492e" mediaType="text/x-hl7-title+xml">DOSAGE AND ADMINISTRATION</title>
<text ID="INV-293f6889-b231-46ce-8058-aa7c99657a95"><paragraph ID="INV-a7d66e8d-f332-4db9-a9d9-8b4623577059">As directed by a
                            physician. Dosage is dependent upon the age, weight and clinical
                            condition of the patient as well as laboratory determinations.</paragraph><paragraph ID="INV-981c5e22-9fb7-49c5-8423-59dbd9a36d79">Parenteral drug
                            products should be inspected visually for particulate matter and
                            discoloration prior to administration whenever solution and container            permit.</paragraph><paragraph ID="INV-7a968364-79d8-4463-8215-f4b49b3b8059">All injections in
                            VIAFLEX plastic containers are intended for intravenous administration
                            using sterile equipment.</paragraph><paragraph ID="INV-2c1c5422-9875-4c3d-8dec-64b80e4311d0">Additives may be
                            incompatible. Complete information is not available. Those additives
                            known to be incompatible should not be used. Consult with pharmacist, if
                            available. If, in the informed judgment of the physician, it is deemed
                            advisable to introduce additives, use aseptic technique. Mix thoroughly
                            when additives have been introduced. Do not store solutions containing
                            additives.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-46eb48fd-8f18-47a7-8dd8-31b3b3ba7c1e">
<id root="C990E9D1-86BF-1928-B5D4-022D8FFA385E" />
<code code="34069-5" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="HOW SUPPLIED SECTION" />
<title ID="INV-11e11b41-d69a-4ce3-a6f8-ef2f07639136" mediaType="text/x-hl7-title+xml">HOW SUPPLIED</title>
<text ID="INV-49bb349d-9938-4c8e-a775-a524cc26e69b"><paragraph ID="INV-e77c5201-f3e0-478e-aee0-1c1f4d2bbf5e">Lactated Ringer&#8217;s
                            Injection, USP in VIAFLEX plastic container is available as follows:</paragraph><table frame="void"><col align="left" width="140pt" />
<col align="left" width="140pt" />
<col align="left" width="140pt" />
<tbody valign="top">
<tr valign="top"><td align="left" valign="middle"><content styleCode="bold">Code</content></td><td align="left" valign="middle"><content styleCode="bold">Size (mL)</content></td><td align="left" valign="middle"><content styleCode="bold">NDC</content></td></tr>
<tr valign="top"><td align="left" valign="middle">
                                        2B2322 </td><td align="left" valign="middle"> 250 </td><td align="left" valign="middle">
                                        0338-0117-02 </td></tr>
<tr valign="top"><td align="left" valign="middle">
                                        2B2323 </td><td align="left" valign="middle"> 500 </td><td align="left" valign="middle">
                                        0338-0117-03 </td></tr>
<tr valign="top"><td align="left" valign="middle"> 2B2324 </td><td align="left" valign="middle"> 1000 </td><td align="left" valign="middle"> 0338-0117-04 </td></tr>
</tbody>
</table><paragraph ID="INV-9eb677be-3689-4ded-ba7b-f65c2a3be3cb">Exposure of
                            pharmaceutical products to heat should be minimized. Avoid excessive
                            heat. It is recommended the product be stored at room temperature
                            (25&#176;C); brief exposure up to 40&#176;C does not adversely affect the         product.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-e15b3991-7871-4593-b9b3-72307b886bb3">
<id root="FBFFF613-F5F6-AD07-DDA8-C08CC5C17C46" />
<code code="38056-8" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="SUPPLEMENTAL PATIENT MATERIAL" />
<title ID="INV-c1fb2f06-7cee-4845-822c-0fd08947f51a" mediaType="text/x-hl7-title+xml">DIRECTIONS FOR USE OF
                        VIAFLEX PLASTIC CONTAINER</title>
<text ID="INV-51aefaa0-136c-4074-a37a-11da6eaa3545"><paragraph ID="INV-f7b0da15-f5e7-4a44-8925-acb3131a23c7"><content styleCode="bold">WARNING:</content> Do not use plastic containers in                         series connections. Such use could result in air embolism due to
                            residual air being drawn from the primary container before
                            administration of the fluid from the secondary container is
                        completed.</paragraph></text>
<effectiveTime value="20060608" />
<component>
<section ID="INV-cec397a3-6600-4ef4-a1b6-86b0df19f0a0">
<id root="742D4EDD-1A32-0397-7ED4-514A025DEEE5" />
<title ID="INV-b7fc5a15-7b1a-4e36-9121-3eebe054d7f0" mediaType="text/x-hl7-title+xml">To Open</title>
<text ID="INV-500ea581-8797-49e5-a5d2-34637522142c"><paragraph ID="INV-141bfe41-6fe1-4a13-adb6-9baed96ac776">Tear
                                    overwrap down side at slit and remove solution container. Some
                                    opacity of the plastic due to moisture absorption during the
                                    sterilization process may be observed. This is normal and does
                                    not affect the solution quality or safety. The opacity will
                                    diminish gradually. Check for minute leaks by squeezing inner
                                    bag firmly. If leaks are found, discard solution as sterility
                                    may be impaired. If supplemental medication is desired, follow
                                    directions below.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-dbf612db-3c3c-479b-8de6-c948187a2cae">
<id root="B828A1AF-D009-ED46-41FF-5686457CBA8A" />
<title ID="INV-19ca05d6-310c-4bf2-bf33-2b01c11150af" mediaType="text/x-hl7-title+xml">Preparation for
                                Administration</title>
<text ID="INV-1079900f-1fe5-4718-811f-52914ca1bf38"><paragraph ID="INV-3d710670-0e71-4893-ae6f-75210ca012bc">1. Suspend
                                    container from eyelet support.</paragraph><paragraph ID="INV-3b3ea8df-f637-4e62-b861-7ded92f8cf0d">2. Remove
                                    plastic protector from outlet port at bottom of container.</paragraph><paragraph ID="INV-ab7eef57-d9f9-4131-a439-c70cb04284ee">3. Attach
                                    administration set. Refer to complete directions accompanying
                                    set.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-d895c3fe-e6b2-4b4b-98f4-3a84c5adb538">
<id root="ED552866-792C-4ACA-9760-318286F79DEB" />
<title ID="INV-595630a9-2a72-4808-83e9-c5af57a2e00d" mediaType="text/x-hl7-title+xml">To Add Medication</title>
<text ID="INV-14cf0e9f-0073-4044-b89b-db38734fec08"><paragraph ID="INV-a76a40de-89ba-4e36-b4e0-2194442a0813"><content styleCode="bold">WARNING:</content> Additives may be
                                    incompatible.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-c945fd32-8581-4817-99bd-8841c34b5ec2">
<id root="E63F5A86-791E-F5F6-EA24-1AB7CA4EE429" />
<title ID="INV-b5f7679f-86a6-487a-9711-d83b9bf25041" mediaType="text/x-hl7-title+xml">To add medication
                                before solution administration</title>
<text ID="INV-f63345c9-090b-4c7c-9e60-e2d232df9f10"><paragraph ID="INV-3dfd5727-3d66-4132-a183-f798842f134c">1. Prepare
                                    medication site.</paragraph><paragraph ID="INV-c9eade2b-a51d-44bd-af07-304c44cf93fd">2. Using
                                    syringe with 19 to 22 gauge needle, puncture medication port and
                                    inject.</paragraph><paragraph ID="INV-504b45bd-2521-461e-ba41-447f2f48c716">3. Mix
                                    solution and medication thoroughly. For high density medication
                                    such as potassium chloride, squeeze ports while ports are
                                    upright and mix thoroughly.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
<component>
<section ID="INV-8913c05d-08b1-400b-90a0-c9479f025f44">
<id root="94AF43B9-D699-FAB2-CB99-FC6C46EA4B83" />
<title ID="INV-535c4a83-94de-4b73-9bcc-7e4bb0fc4b70" mediaType="text/x-hl7-title+xml">To add medication             during solution administration</title>
<text ID="INV-ed23740c-ef1e-44fb-9baf-d16152e5bf30"><paragraph ID="INV-c10dc0d5-5320-4d01-9cc8-bf53e2534bd6">1. Close
                                    clamp on the set.</paragraph><paragraph ID="INV-3b0af3cc-ea5c-4794-b548-f5d8b4e7079e">2. Prepare
                                    medication site.</paragraph><paragraph ID="INV-3be56b8a-c182-46bf-a0c5-c4bf059ffc1b">3. Using
                                    syringe with 19 to 22 gauge needle, puncture resealable
                                    medication port and inject.</paragraph><paragraph ID="INV-212a1d8c-020a-4c5c-8812-f13e1d3da551">4. Remove
                                    container from IV pole and/or turn to an upright position.</paragraph><paragraph ID="INV-176773ac-99f3-4dab-bd0c-af9cd12a6873">5. Evacuate
                                    both ports by squeezing them while container is in the upright
                                    position.</paragraph><paragraph ID="INV-c5579092-5bf0-4436-bdd1-f4e9b0e35ece">6. Mix
                                    solution and medication thoroughly.</paragraph><paragraph ID="INV-804698cb-7730-4427-ad9c-40b9be23c11b">7. Return
                                    container to in use position and continue administration.</paragraph><paragraph ID="INV-67b6f440-b059-44d7-9d24-9adc1fe73e18"><content styleCode="bold">Baxter Healthcare
                                    Corporation</content></paragraph><paragraph ID="INV-3738cd4a-5800-4775-82d2-fbf35c1d5167">Deerfield,
                                    IL 60015 USA</paragraph><paragraph ID="INV-60ab8944-8fa4-47ec-a6e8-880b1fdac681">Printed in
                                    USA</paragraph><paragraph ID="INV-219a5445-a2dc-4700-ad16-7d8dde851759">&#169;Copyright
                                    1978, 1981, 1982, 1983, 1984, 1989, 1994, 1995,</paragraph><paragraph ID="INV-1b443c1e-5c23-4b04-ba5c-32ae528896ca">Baxter
                                    Healthcare Corporation. All rights reserved.</paragraph><paragraph ID="INV-57598397-9df1-457e-82ed-4c6ae46df8f1"><content styleCode="bold">7-19-39-661 Rev. July 2003</content></paragraph><paragraph ID="INV-77f2d620-a96c-4035-98ee-551b7f4aaa80">BAXTER,
                                    VIAFLEX, and PL 146 are trademarks of</paragraph><paragraph ID="INV-6f2f0401-7bc6-4d85-8977-16a8b2aa6a28">Baxter
                                    International Inc.</paragraph></text>
<effectiveTime value="20060608" />
</section>
</component>
</section>
</component>
</structuredBody>
</component>
</document>
